Robert Ford, Chairman and CEO, reported organic sales growth of 7.5% excluding COVID test sales, highlighting double-digit growth in Medical Devices and high single-digit growth in Established ...
CEO Adam Greenlee emphasized the company’s strong 2024 performance, achieving mid-single-digit organic adjusted EPS growth and double-digit free cash flow growth despite challenges like customer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback